InvestorsHub Logo
Followers 67
Posts 823
Boards Moderated 0
Alias Born 03/19/2009

Re: None

Monday, 09/10/2012 12:25:01 PM

Monday, September 10, 2012 12:25:01 PM

Post# of 2866
Celartia bioreactors.....

From the 7/24/2012 VODG press release.....

A strategic goal moving forward, is an additional partner to supply devices needed for FDA-compliant manufacture of clinical materials for use in pre-clinical and clinical studies. These devices are known as bio-reactors that allow for highly controlled and reproducible production of large numbers of stem cells needed to provide therapeutic benefit. Several characteristics of these bioreactors are essential in reaching the demanding goals needed to achieve regulatory compliant manufacturing to support stem cell therapy that maintains rigorous standards of safety and efficacy. We are presently evaluating suitable devices for this application that appear to be well-suited to the required needs, specifications and characteristics.



Based on Pete Shuster's (Neuromics CEO) Twitter/blog comments over the last few days, it appears that VODG/Neuromics will most likely use bioreactors produced by Celartia......

I have been promoting the capabilities of our new PetakaTM Cell Culturing Systems. My confidence that you will be delighted with these capabilities is based, in part, on the success Dr. Jim Musick, CEO, Vitro Biopharma had culturing our UCB derived Human Mesenchymal Stem Cells.

These cells work "hand in glove" with Petaka. The system enabled Jim to:

•Culture the cells with out the addition of CO2 or humidity (no environmental dehydration)-no incubator required.
•Use less growth media
•Drive the cells into dormancy enabling them to be maintaned, shipped and stored at Room Temperature.



http://neuromics.blogspot.com/2012/09/hmscspetakaexcellent-sc-cultures.html

Pete Shuster's Twitter account.....

http://twitter.com/stratoman1

Celartia website.....

http://www.celartia.com/index.php/usa/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.